Reproducibility of CT perfusion parameters in liver tumors and normal liver

Radiology

Volumn 260, Issue 3, 2011, Pages 762-770

  Ng, Chaan S ^a   Chandler, Adam G ^a,b   Wei, Wei ^a   Herron, Delise H ^a   Anderson, Ella F ^a   Kurzrock, Razelle ^a   Charnsangavej, Chusilp ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD VOLUME; BREATH HOLDING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC PERFUSION IMAGING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER TUMOR; MALE; MEAN TRANSIT TIME; MOTION; PERMEABILITY SURFACE AREA PRODUCT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; TISSUE PERFUSION; TUMOR BLOOD FLOW;

AGED; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84860389713     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110331     Document Type: Article

References (21)

1. Miles K.A., Griffiths M.R. Perfusion CT: A worthwhile enhancement? Br J Radiol 2003; 76(904):220-231. (Pubitemid 36582066)
2. Kambadakone A.R., Sahani D.V. Body perfusion CT: Technique, clinical applications, and advances. Radiol Clin North Am 2009;47(1):161-178.
3. Choi H., Charnsangavej C., De Castro Faria S., et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183(6):1619-1628. (Pubitemid 44210530)
4. Stevenson J.P., Rosen M., Sun W., et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: Magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 2003;21(23):4428-4438. (Pubitemid 46621821)
5. Morgan B., Thomas A.L., Drevs J., et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two phase I studies. J Clin Oncol 2003;21(21):3955- 3964. (Pubitemid 46606209)
6. Husband J.E., Reznek R.H. Husband & Reznek's imaging in oncology. 3rd ed. London, England: Informa Healthcare, 2010.
7. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340(10):745-750. (Pubitemid 29114292)
8. Gillard J.H., Antoun N.M., Burnet N.G., Pickard J.D. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 2001;74(882):552-555. (Pubitemid 32674216)
9. Gandhi D., Chepeha D.B., Miller T., et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27(1):101-106. (Pubitemid 46939894)
10. Sahani D.V., Holalkere N-S, Mueller P.R., Zhu A.X. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - Initial experience. Radiology 2007;243(3):736-743. (Pubitemid 46799427)
11. Ng Q.S., Goh V., Fichte H., et al. Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements . Radiology 2006;239(2):547-553.
12. Stewart E.E., Chen X., Hadway J., Lee T.Y. Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model. Radiology 2006;239(3):740-750. (Pubitemid 43830609)
13. Stewart E.E., Chen X., Hadway J., Lee T.Y. Hepatic perfusion in a tumor model using DCE-CT: An accuracy and precision study. Phys Med Biol 2008;53(16):4249-4267.
14. Galbraith S.M., Lodge M.A., Taylor N.J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15(2):132-142. (Pubitemid 34213403)
15. Bland J.M., Altman D.G. Measurement error proportional to the mean. BMJ 1996; 313(7049):106. (Pubitemid 26257767)
16. Lee T.Y. Functional CT: Physiological models. Trends Biotechnol 2002;20(8 Suppl):S3-S10.
17. Goh V., Halligan S., Hugill J.A., Gartner L., Bartram C.I. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: Effect of acquisition time and implications for protocols. J Comput Assist Tomogr 2005;29(1):59-63. (Pubitemid 40194439)
18. Purdie T.G., Henderson E., Lee T.Y. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001; 46(12):3161-3175. (Pubitemid 34568065)
19. Goh V., Halligan S., Hugill J.A., Bartram C.I. Quantitative assessment of tissue perfusion using MDCT: Comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol 2006;187(1): 164-169. (Pubitemid 46100163)
20. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310. (Pubitemid 16134762)
21. Cenic A., Nabavi D.G., Craen R.A., Gelb A.W., Lee TYA A CT method to measure hemodynamics in brain tumors: Validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21(3):462-470. (Pubitemid 30149336)